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SC1/PRMT5  histone  methyltransferase  activity  is down-regulated  by  NGF,  but not  EGF.
NGF  reduces  the nuclear,  but  not  the cytosolic  SC1/PRMT5-mediated  HMTase  activity.
SC1  and  PRMT5  are  found  in the  nucleus  and  the cytosol  of primary  mouse  neurons.
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a  b  s  t  r  a  c  t
During  neuronal  development,  the  neuroepithelial  stem  cells  (NSCs)  initially  undergo  proliferative  divi-
sions, later  switching  to neurogenic  ones  whereby  one  NSC  and  a post-mitotic  neuron  are  generated.  We
recently  showed  that  a member  of  the PRDM  family  of  transcriptional  regulators,  PRDM4/SC1,  recruits
a  type  II protein  arginine  methyltransferase,  PRMT5,  to  maintain  the  “stem-like”  cellular  state  of  theeywords:
RDM4
RMT5
istone arginine methylation
C12 cells
embryonic  mouse  cortical  NSCs.  However,  little  is known  about  the  regulation  of  activity  of  this  complex
under  proliferation-  or  differentiation-inducing  growth  conditions.
In the  present  work  I investigate  the  regulation  of  SC1/PRMT5-mediated  methylation  activity  in  PC12
cells  treated  with  EGF  or NGF.  I present  evidence  that NGF  down-regulates  SC1/PRMT5  methyltransferase
(MTase)  activity  and that the  reduction  in SC1/PRMT5  MTase  activity  occurs mainly  in the  nucleus.  I
suggest  that  high  levels  of SC1/PRMT5  activity  are  associated  with  the  proliferative  state  of  the  cells.GF
. Introduction
During cortical development, the neuroepithelial stem cells
nitially proliferate to increase their numbers and later differen-
iate generating neurons and glia [20,23]. In part the decisions
f the developing NSCs to continue proliferation or to commit to
 differentiation programme are cell-intrinsic [14,15]. Addition-
lly, extracellular growth factors regulate cell fate decisions of the
recursor cells during development. Intriguingly, various growth
actors bind to their cognate receptors to activate seemingly identi-
al downstream pathway, leading to dramatically different cellular
Abbreviations: SC1, Schwann cell factor 1; PRMT, protein arginine methyltrans-
erase; PRDM, positive regulatory domain protein; NGF, nerve growth factor; EGF,
pidermal growth factor; NSC, neural stem cells; (H)MTase, (histone) methyltrans-
erase.
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∗ Tel.: +44 0 207 679 6272; fax: +44 0797 390 5794.
E-mail address: a.chittka@ucl.ac.uk
304-3940/$ – see front matter ©  2013 The Author. Published by Elsevier Ireland Ltd. All
ttp://dx.doi.org/10.1016/j.neulet.2013.06.051© 2013 The Author. Published by Elsevier Ireland Ltd. All rights reserved.
responses. For example, neurotrophins, e.g. the Nerve Growth Fac-
tor (NGF), activate receptor tyrosine kinases, but so do growth
factors such as the Epidermal Growth Factor (EGF) [4]. However,
the biological responses are either differentiation and cell cycle exit
or proliferation, respectively [4].
Neurotrophins regulate many aspects of neuronal development
via activation of two types of receptors, the low afﬁnity p75
neurotrophin receptor, p75NTR, and a family of receptor tyro-
sine kinases, the Trk receptors, TrkA, TrkB and TrkC [24]. PC12
cells provide a convenient cellular system to investigate the dif-
ferences in the signalling mechanisms of the neurotrophins and
proliferation-inducing factors, e.g., EGF. PC12 cells express both the
p75NTR and TrkA receptors and respond to NGF by differentiating
into sympathetic-like neurons and to EGF or serum by proliferat-
ing [30]. The duration of ERK kinase activation is one of the critical
parameters in distinguishing cellular response to either NGF or EGF
in these cells [3,19,21].We recently demonstrated that a p75NTR interacting protein,
PRDM4/SC1 (referred to as SC1 henceforth), recruits a type II pro-
tein arginine methyltransferase, PRMT5, to direct histone arginine
methylation in the neural precursor cells from the developing
 rights reserved.
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ouse cortex [7]. Moreover, one of the PRMT5-mediated his-
one modiﬁcations, namely histone H4 arginine 3 symmetric
imethylation (H4R3me2s) is a signature of the early proliferating
euroepithelium prior to the onset of neurogenesis [5]. Together
hese observations suggest that high levels of methyltransferase
MTase) activity of the SC1/PRMT5 complex may  maintain the
roliferative status of the NSCs. Recent investigations into the
echanisms responsible for growth- or differentiation-promoting
ctivities identiﬁed PRMT5 as one of the critical modulators of EGF-
r NGF-mediated biological responses in PC12 cells demonstrating
hat NGF reduces PRMT5 enzymatic activity [2]. I reasoned that
C1/PRMT5-mediated protein/histone arginine methylation may
epresent a subset of targets for PRMT5 methylation and that the
ctivity of this complex may  be differentially regulated by different
ypes of growth factors, e.g., EGF and NGF in PC12 cells.
I demonstrate that NGF down-regulates SC1/PRMT5-mediated
Tase activity consistent with the previously published observa-
ions that PRMT5 activity in PC12 cells is dampened by NGF [2].
oreover, NGF-induced reduction in SC1/PRMT5-mediated MTase
ctivity is conﬁned to the nucleus, but not the cytosol of PC12 cells.
GF, however, sustains similar amounts of MTase activity by the
omplex in both cellular compartments. Finally, I show that both
C1 and PRMT5 are found in the nucleus and the cytosol of the early
orn primary mouse cortical neurons.
. Materials and methods
.1. Cell culture and transfections
PC12 cells were cultured in DMEM (Invitrogen) supplemented
ith 10% (v/v) horse serum (HS), 5% (v/v) foetal calf serum (FCS)
nd glutamine. For growth factor treatment the serum content
as lowered to 1% HS. EGF (PeproTech) was used at 20 ng/ml,
GF (PeproTech) - at 50 ng/ml. Transfections were performed
sing Lipofectamine 2000 (Invitrogen) according to the manufac-
urer’s instructions. 48 h post-transfection cells were treated with
he indicated growth factors, lysed and processed for the histone
ethyltransferase activity (HMTase) as described [7].
.2. Immunoprecipitation and methylation assays
PC12 cells were harvested in immunoprecipitation (IP) buffer
50mM Tris–HCl, pH7.4, 0.5% (v/v) Nonidet P-40, 300 mM NaCl)
upplemented with the protease inhibitor cocktail (Sigma) and
hosphatase inhibitor cocktails 1 and 2 (Sigma), processed as pre-
iously described and collected on protein A/G beads (Santa Cruz)
7]. After washing, beads with immunoprecipitated (IPed) proteins
ere processed for a radioactive in vitro HMTase assay as previ-
usly described using a mixture of puriﬁed calf thymus histones
Roche Applied Science) [7]. Products of HMTase reactions were
eparated by SDS-PAGE, transferred onto polyvinylidene diﬂuoride
PVDF) membranes (Millipore) and visualized using ﬂuorography.
.3. Subcellular fractionation of the cells and histone extraction
PC12 cells treated as speciﬁed were harvested and processed
or cytoplasmic and nuclear fractionation. Cells were rinsed in cold
BS on ice, scraped off the plates, resuspended in Hypotonic Buffer A
HBA) (10 mM HEPES-K+ pH7.5, 10 mM KCl, 1.5 mM MgCl2, 0.5 DTT)
upplemented with protease (Sigma) and phosphatase inhibitors
Sigma) and pelleted by centrifugation at 1000 rpm for 5 min at
◦C. HBA was supplemented with NP40 to a ﬁnal concentration
f 0.5% and added to the pellet to lyse the cells for 10 minutes
re 4 ◦C. Nuclei were pelleted at 3000 rpm for 2 min  at 4 ◦C and
he supernatants collected as the cytosolic fraction, aliquoted and
tored at −80 ◦C. Pellets containing nuclei were washed with HBAers 550 (2013) 87– 92
without NP40, followed by resuspension in buffer C (20 mM  HEPES-
K+ pH 7.9, 420 mM NaCl, 0.2 mM EDTA, 1.5 mM MgCl2, 0.5 DTT, 25%
Glycerol) supplemented with protease and phosphatase inhibitors.
Nuclear proteins were extracted for 30 min  on ice with regular vor-
texing. The suspension was  centrifuged at 4 ◦C for 10 min  and the
supernatant containing nuclear proteins collected, aliquoted and
stored at −80 ◦C or used for HMTase assays immediately.
Histones were extracted from PC12 cells as follows. Cells were
washed twice in cold PBS, lysed in Triton extraction buffer (TEB:
PBS, 0.5% Triton X 100 (v/v), 2 mM phenylmethylsulfonyl ﬂuoride
(PMSF), 0.02% (v/v) NaN3) for 10 min  on ice, centrifuged at 2000 rpm
for 10 min  at 4 ◦C, the supernatants discarded, pellets washed again
in half the volume of TEB and centrifuged as before. Pellets were
resuspended in 0.2 N HCl and extracted overnight at 4 ◦C. Extracts
were centrifuged at 2000 rpm for 10 min  at 4 ◦C and the super-
natants used for SDS-PAGE.
2.4. Western blotting, immunocytochemistry and antibodies used
Western blotting was performed in TBST buffer (100 mM
Tris–HCl, pH 7.5, 150 mM NaCl, 0.1% (v/v) Tween 20). For IP’s and
Western blotting the following antibodies were used: anti-myc
(Upstate, 1:1000 for Western blotting), anti-H3 (Abcam, 1:1000),
anti-H4 (Abcam, 1:500), anti-H4R3me2s (Abcam, 1:1000), anti-
H4R3me2a (asymmetric dimethyl, Active Motif, 1:1000), anti-TBP
(Abcam 1:2000), anti--tubulin (Abcam, 1:5000). The following
antibodies were used for immunocytochemistry: anti-TuJ1 (Sigma,
1:500), anti-PRMT5 (Upstate Biotech, 1:100), anti-SC1/PRDM4 (a
gift from Pilar Perez and Moses Chao (1:40) and our own (1:100)
[6,7]). For immunocytochemical detection of antigens, primary
neural stem cells were processed as previously described [7]. Fluo-
rescent images were collected using the Leica Microsystems SPE
confocal microscope. The following secondary antibodies were
used: goat anti-rabbit Alexa 488, goat anti-mouse Alexa 568 (Invi-
trogen).
2.5. Primary neural stem cell cultures
Primary cortical neural stem cells were isolated from time
mated mouse E10.5 embryos according to a published protocol
[7] and plated at a density of 2.5 × 105 cells/13 mm on glass cover
slips. NSCs were cultured in DMEM supplemented with 40 ng/ml
Neurotrophin-3 (NT-3) (Pepro Tech), 0.25% FCS, B27 supplement,
sodium pyruvate and glutamine (all from Invitrogen). Animal
experiments were approved by the University College London local
ethical committee and conformed to the UK Animals (Scientiﬁc
Procedures) Act 1986. Project license number PPL 70/6697.
3. Results
3.1. NGF down-regulates SC1/PRMT5-mediated HMTase activity
We  recently demonstrated that SC1 recruits the protein arginine
methyltransferase, PRMT5, to mediate symmetric dimethylation
of histone H4 on arginine 3 (H4R3me2s) [7] and showed that
H4R3me2s modiﬁcation mediated by PRMT5 is a “signature” of
proliferating neuroepithelium in the developing mouse cortex
[5]. These observations suggest that the SC1/PRMT5-mediated
MTase activity may be subject to regulation by extracellular sig-
nals which instruct the NSCs to either proliferate or differentiate.
To investigate whether SC1/PRMT5 MTase activity is regulated
by differentiation or proliferation-inducing factors, I used PC12
cells which respond to NGF and EGF by differentiating into
sympathetic-like neurons or by proliferating, respectively [30]. To
determine if SC1 interacts with PRMT5 in PC12 cells, I transiently
transfected PC12 cells with either Myc-tagged SC1- (mycSC1) or
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Fig. 1. NGF down-regulates SC1/PRMT5-mediated HMTase activity in PC12 cells.
(A) mycSC1 or Myc-tag alone were overexpressed in PC12 cells, the proteins IPed
using anti-myc antibody and used for an in vitro HMTase assay with puriﬁed calf thy-
mus  histones. The products of HMTase reaction were probed with anti-H4R3me2s
antibodies (top panel) and with anti-H4 antibodies to control for the histone load-
ing (2nd panel from the top). Input, IPed and co-iped proteins were detected by
using indicated antibodies to detect endogenous PRMT5 or mycSC1 (middle two
and  bottom two panels, respectively). (B) Transfected PC12 cells were cultured with
serum, EGF or NGF as indicated. Overexpressed myc  and mycSC1 were IPed and
used for in vitro radioactive HMTase assay with puriﬁed calf thymus histones. Top
panel: HMTase reaction products; 2nd, 3rd and bottom panels - Western blots probed
with: anti-H3 antibody to control for the histone loading; anti-myc antibody to
detect IPed mycSC1 protein, anti-PRMT5 antibody to detect PRMT5, respectively.
(C)  Quantiﬁcation of normalized HMTase activity detected in PC12 cells grown in
serum, EGF or NGF. Relative HMTase activity was normalized to PRMT5 levels in the
lysates (means ± S.D., n = 3, t test, P < 0.001). AU: arbitrary units; n.s.: not signiﬁcant;
F:  ﬂuorogram; IP: immunoprecipitation; WB:  Western blot.
Fig. 2. NGF treatment of PC12 cells reduces SC1/PRMT5-mediated HMTase activ-
ity  in the nucleus. (A) PC12 cells were transfected as in Fig. 1, treated for 2.5 h
with EGF or NGF 48 h post-transfection and fractionated into nuclear and cytosolic
fractions. Overexpressed proteins were IPed from cellular fractions using anti-myc
antibodies and used for an in vitro radioactive HMTase assay. Products of the
HMTase reactions are shown in the ﬂuorogram, top panel. Below is the Western
blot using anti-H3 antibodies to control for histone loading. The middle panel shows
IPed proteins from the nuclear and cytosolic fractions in the indicated reactions.
The fourth panel shows endogenous PRMT5 in the lysates used for HMTase assay.
Purity of subcellular fractions was  evaluated by probing the blots with anti-tubulin
and  anti-TATA-binding protein (TBP) antibodies for cytosolic and nuclear fraction,
respectively (bottom two panels). (B) Quantiﬁcation of normalized HMTase activity
ratio in the cytosolic/nuclear fractions of EGF or NGF treated PC12 cells. Relative
HMTase activity was  normalized to PRMT5 protein levels in the nuclear or cyto-
solic  fraction (means ± S.D., n = 3, t test, P < 0.001). (C) Transfected PC12 cells were
treated as in panel A, cellular histones extracted and probed with anti-H4R3me2s
and  H4R3me2a (asymmetric H4R3 dimethylation) antibodies; total H4 was  detected
with anti-H4 antibodies. Bottom panels show overexpressed mycSC1 protein from
transfected PC12 cells. F: ﬂuorogram; WB:  Western blot; IP: immunoprecipitation;
AU: arbitrary units.
Myc-tag- overexpressing plasmids and immunoprecipitated over-
expressed proteins 48 h post-transfection using anti-myc antibod-
ies. A complex between mycSC1 and the endogenous PRMT5, but
not between Myc-tag alone and PRMT5 was  detected in PC12 cells
(Fig. 1A, 3rd panel from the top). Moreover, an in vitro HMTase
assay using the immunoprecipitated proteins revealed an increase
in the amount of H4R3me2s methylation consistent with the pres-
ence of PRMT5 in mycSC1 immunoprecipitated complex (Fig. 1A,
top panel). To test whether EGF and NGF regulate SC1/PRMT5-
mediated MTase activity in PC12 cells, the cells were transfected
with mycSC1- or Myc-tag-overexpressing plasmids and treated
with EGF or NGF 48 h post-transfection for indicated times. Fol-
lowing growth factor treatment mycSC1 or Myc-tag proteins were
immunoprecipitated (Fig. 1B, 3rd panel) and an in vitro radioactive
HMTase assay with exogenously added puriﬁed calf thymus histone
mixture was performed [7]. NGF treatment consistently lowered
HMTase activity associated with SC1 (Fig. 1B, top panel, lane 2.5 h
NGF, quantiﬁed in Fig. 1C). In PC12 cells SC1/PRMT5-associated
HMTase activity had a higher preference for histone H3 than for his-
tone H4 (Fig. 1B, top panel). PRMT5 substrate preference for H4 is in
part mediated by a protein COPR5, whose absence leads to a higher
90 A. Chittka / Neuroscience Letters 550 (2013) 87– 92
Fig. 3. SC1 and PRMT5 are found in the nucleus and the cytoplasm of early differentiating neurons. NSCs isolated at E10.5 were cultured in the presence of NT3 to
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howing Hoechst staining of DNA are shown on the right. Magniﬁed images of the
RMT5  in both perinuclear and axonal parts of young neurons. Scale bar is 25 m.
reference for methylating H3R8 by PRMT5 [17] –a likely expla-
ation for the preferred methylation of H3 observed in PC12 cells.
reatment of PC12 cells with EGF did not lead to any detectable
hange in the amount of SC1/PRMT5-mediated histone methyla-
ion (Fig. 1B, EGF lanes). Neither NGF nor EGF treatment affected
he levels of PRMT5 protein (Fig. 1B, bottom panel), suggesting that
GF reduces SC1/PRMT5-mediated MTase activity.
.2. NGF-dependent reduction in SC1/PRMT5-mediated MTase
ctivity is conﬁned to the nucleus
Both SC1 and PRMT5 are found in the cytosol and in the
ucleus [7,29]. PRMT5 methylates proteins in both compart-
ents [2,29,31]. To investigate whether EGF and NGF regulate
C1/PRMT5-mediated MTase activity differentially within the cyto-
ol and the nucleus, PC12 cells were transfected as described above
nd treated with either EGF or NGF for 2.5 h. Cells were lysed,
eparated into nuclear and cytosolic fractions, mycSC1 or Myc-tag
roteins immunoprecipitated and an in vitro radioactive HMTase
ssay performed. NGF, but not EGF treatment induced a reduction
n the amount of SC1/PRMT5-mediated HMTase activity within the
uclear compartment (Fig. 2A, top panel, compare NGF and EGF
anes, quantiﬁed in panel B).
NGF is known to increase asymmetrically dimethylated pro-
eins [8]. We  therefore investigated whether a change in the
mount of endogenous histone arginine methylation (symmetric
nd asymmetric) is detectable in PC12 cells transfected and treated
s described above. Histones extracted from PC12 cells followinges to visualize PRMT5, SC1 and TuJ1 to identify early-born neurons. Merged images
 areas from merged panels highlight (white arrowheads) the presence of SC1 and
growth factor treatment, were subjected to a Western blot analysis
with anti-H4R3me2s and anti-H4R3me2a antibodies. No signiﬁ-
cant change in the magnitude of H4R3me2s or H4R3me2a was
detected in the EGF or NGF treated samples (Fig. 2C), suggesting
that the histone modiﬁcations mediated by SC1/PRMT5 complex
target a subset of speciﬁc gene loci which may  not be detectable as
an overall change in histone arginine methylation levels. Thus, NGF
down-regulates SC1/PRMT5-mediated MTase activity within the
nuclear compartment of PC12 cells without affecting total histone
arginine methylation of H4R3.
3.3. SC1 and PRMT5 are found in the nucleus and the cytosol of
the early-born neurons
The observations, that NGF induced a selective reduction of
the nuclear SC1/PRMT5-mediated MTase activity in PC12 cells,
prompted me  to investigate the subcellular distribution of SC1
and PRMT5 in differentiating neurons from the developing mouse
cortex. Cortical NSCs isolated from E10.5 mouse embryos were
cultured in NT3-containing media for 3 days to induce neuro-
genesis. Early-born neurons were detected by immunostaining
cells with antibodies against Tuj1. Subcellular localization of SC1
and PRMT5 in early-born neurons was determined by immunos-
taining cells with appropriate antibodies. Both proteins were
detected in the nucleus and cytosol of neurons (Fig. 3), sug-
gesting that in differentiating neurons SC1/PRMT5 complex may
mediate methylation of proteins in both subcellular compart-
ments.
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. Discussion
Presented results demonstrate that SC1/PRMT5-mediated
Tase activity is reduced by NGF, and sustained by EGF in PC12
ells. These observations are in line with the previously pub-
ished report that NGF dampens PRMT5 activity in PC12 cells
2] and highlight the importance of protein/histone arginine
ethylation in directing cellular decisions to proliferate or differ-
ntiate [2,29]. Moreover, PRDM proteins are emerging as important
egulators of developmental commitment decisions within the pro-
enitor cells in multiple tissues, including the nervous system
1,9–13,16,18,25–28,31].
Our previous work identiﬁed PRMT5-mediated deposition of
4R3me2s modiﬁcations as a “signature” of proliferating embry-
nic cortical NSCs suggesting a role for PRMT5 in the control of NSC
roliferation and “stemness” [5]. Moreover, we previously showed
hat silencing SC1 expression in proliferating NSCs induces preco-
ious neurogenesis [7], suggesting that the SC1/PRMT5-mediated
istone modiﬁcations may  “write” part of the “histone code” for
he proliferative cellular state of the NSCs. Therefore the observa-
ion that SC1/PRMT5-mediated MTase activity is down-regulated
y NGF in PC12 cells is consistent with the idea that dampening the
ctivity of this complex favours differentiation.
Another interesting observation is the selective, NGF-induced
eduction of SC1/PRMT5-mediated MTase activity in the nucleus of
C12 cells. The decrease in the nuclear SC1/PRMT5 MTase activity
s likely to result in a diminution of proteins symmetrically dime-
hylated by the complex within this compartment. Interestingly,
istones may  not be the only targets of NGF-dependent reduc-
ion of SC1/PRMT5-mediated protein methylation as no notable
hange in the overall H4R3me2s was observed in PC12 cells
verexpressing SC1 and treated with NGF. Perhaps other nuclear
roteins are also substrates of SC1/PRMT5-mediated symmetric
rginine dimethylation down-regulated by NGF. This possibility
s consistent with the previously published report demonstrat-
ng NGF-dependent increase in the amount of asymmetrically
imethylated proteins in the nucleus and our previous observa-
ions that asymmetric dimethylation of H4R3 is detected in the
ost-mitotic neurons of the developing cortex, but not in the prolif-
rating NSCs where H4R3me2s prevails [5,8]. Thus, high activity of
C1/PRMT5-mediated symmetric protein arginine dimethylation
ithin the nucleus appears to constitute part of the programme
f post-translational protein modiﬁcations which may favour the
roliferative cellular state.
The selective down-regulation of the nuclear SC1/PRMT5-
ediated MTase activity by NGF induces a localized, speciﬁc
esponse of the cells to different growth factors, suggesting that
ome of the decisions between proliferation and differentiation
re regulated by the magnitude of symmetric protein arginine
imethylation within the nuclear compartment. Importantly,
RMT5 has been shown to control ES cell pluripotency by methy-
ating the cytosolic pool of histone H2A in the embryonic stem
ES) cells [29]. Moreover, PRDM16 and 3 mono-methylate a
ytosolic pool of histone H3 on lysine 9 to mediate their biological
unctions [22]. Therefore, selective regulation of the cytosolic and
uclear enzymatic activities of PRMT5 and PRDM proteins may
e an emerging mechanism of cellular re-programming during
evelopment–a topic which remains to be explored in future
tudies.
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